Madrigal Pharmaceuticals inc.
Madrigal Pharmaceuticals inc. (ISIN US5588681057) traded at 442.80 € on August 21, 2026. 3 of 3 sharewise users currently rate it a buy.
Pros & cons of Madrigal Pharmaceuticals
Performance of Madrigal Pharmaceuticals inc. vs. its peers
| Security | YTD | 3y |
|---|---|---|
| Madrigal Pharmaceuticals inc. | -11.17% | 165.31% |
| Heron Therapeutics Inc. | -76.52% | -82.79% |
| Evolus Inc | 28.73% | -18.42% |
| Rhythm Pharmaceuticals | -1.60% | 300.00% |